Clinical Trial Update: The Pain Pen for Breakthrough Cancer Pain [Phase 3]

View source ↗

Summary

Phase 3 study of the Pain Pen for breakthrough cancer pain was terminated; the update reports the study status but provides no results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Pain Pen

Snippet

Sponsor: Erasmus Medical Center | Conditions: Neoplasms, Pain | Phase 3 | Status: TERMINATED